nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—AR—scrotum—leprosy	0.104	0.316	CbGeAlD
Levonorgestrel—SHBG—hindlimb—leprosy	0.0491	0.15	CbGeAlD
Levonorgestrel—Application site reaction—Dapsone—leprosy	0.0346	0.0514	CcSEcCtD
Levonorgestrel—SRD5A1—eye—leprosy	0.0343	0.105	CbGeAlD
Levonorgestrel—Hypochromic anaemia—Thalidomide—leprosy	0.0214	0.0318	CcSEcCtD
Levonorgestrel—PGR—blood vessel—leprosy	0.0211	0.0645	CbGeAlD
Levonorgestrel—Erythema nodosum—Thalidomide—leprosy	0.0192	0.0285	CcSEcCtD
Levonorgestrel—SRD5A1—testis—leprosy	0.0188	0.0574	CbGeAlD
Levonorgestrel—SRD5A1—nervous system—leprosy	0.0185	0.0563	CbGeAlD
Levonorgestrel—Protein urine present—Dapsone—leprosy	0.0182	0.0271	CcSEcCtD
Levonorgestrel—ESR1—blood vessel—leprosy	0.0165	0.0505	CbGeAlD
Levonorgestrel—Enlargement abdomen—Thalidomide—leprosy	0.0138	0.0205	CcSEcCtD
Levonorgestrel—Toothache—Thalidomide—leprosy	0.0136	0.0203	CcSEcCtD
Levonorgestrel—Galactorrhoea—Thalidomide—leprosy	0.0128	0.019	CcSEcCtD
Levonorgestrel—Tooth disorder—Thalidomide—leprosy	0.0128	0.019	CcSEcCtD
Levonorgestrel—Seborrhoeic dermatitis—Thalidomide—leprosy	0.0122	0.0181	CcSEcCtD
Levonorgestrel—Menstrual disorder—Thalidomide—leprosy	0.0122	0.0181	CcSEcCtD
Levonorgestrel—Metrorrhagia—Thalidomide—leprosy	0.0116	0.0173	CcSEcCtD
Levonorgestrel—Influenza—Dapsone—leprosy	0.0102	0.0151	CcSEcCtD
Levonorgestrel—Endocrine disorder—Thalidomide—leprosy	0.01	0.0149	CcSEcCtD
Levonorgestrel—Numbness—Thalidomide—leprosy	0.01	0.0149	CcSEcCtD
Levonorgestrel—Acne—Thalidomide—leprosy	0.00986	0.0147	CcSEcCtD
Levonorgestrel—Sensory loss—Thalidomide—leprosy	0.00958	0.0142	CcSEcCtD
Levonorgestrel—Amenorrhoea—Thalidomide—leprosy	0.00945	0.014	CcSEcCtD
Levonorgestrel—Protein urine present—Thalidomide—leprosy	0.00932	0.0139	CcSEcCtD
Levonorgestrel—Herpes simplex—Thalidomide—leprosy	0.00901	0.0134	CcSEcCtD
Levonorgestrel—Sinusitis—Dapsone—leprosy	0.00851	0.0127	CcSEcCtD
Levonorgestrel—Pharyngitis—Dapsone—leprosy	0.00808	0.012	CcSEcCtD
Levonorgestrel—Candida infection—Thalidomide—leprosy	0.00792	0.0118	CcSEcCtD
Levonorgestrel—AR—skin of body—leprosy	0.0078	0.0238	CbGeAlD
Levonorgestrel—Cramps of lower extremities—Thalidomide—leprosy	0.00762	0.0113	CcSEcCtD
Levonorgestrel—Lightheadedness—Thalidomide—leprosy	0.00743	0.011	CcSEcCtD
Levonorgestrel—Erythema—Dapsone—leprosy	0.00709	0.0105	CcSEcCtD
Levonorgestrel—SHBG—testis—leprosy	0.00685	0.0209	CbGeAlD
Levonorgestrel—Vascular purpura—Thalidomide—leprosy	0.00673	0.01	CcSEcCtD
Levonorgestrel—Eczema—Thalidomide—leprosy	0.0067	0.00997	CcSEcCtD
Levonorgestrel—Libido decreased—Thalidomide—leprosy	0.0065	0.00966	CcSEcCtD
Levonorgestrel—Increased appetite—Thalidomide—leprosy	0.00641	0.00954	CcSEcCtD
Levonorgestrel—Vertigo—Dapsone—leprosy	0.00637	0.00947	CcSEcCtD
Levonorgestrel—Purpura—Thalidomide—leprosy	0.00625	0.0093	CcSEcCtD
Levonorgestrel—Cough—Dapsone—leprosy	0.00618	0.0092	CcSEcCtD
Levonorgestrel—PGR—testis—leprosy	0.00617	0.0188	CbGeAlD
Levonorgestrel—PGR—nervous system—leprosy	0.00605	0.0185	CbGeAlD
Levonorgestrel—Pain in extremity—Thalidomide—leprosy	0.00602	0.00896	CcSEcCtD
Levonorgestrel—Disturbance in sexual arousal—Thalidomide—leprosy	0.00598	0.00889	CcSEcCtD
Levonorgestrel—AR—tendon—leprosy	0.00594	0.0181	CbGeAlD
Levonorgestrel—Migraine—Thalidomide—leprosy	0.00593	0.00882	CcSEcCtD
Levonorgestrel—Affect lability—Thalidomide—leprosy	0.00593	0.00882	CcSEcCtD
Levonorgestrel—Mood swings—Thalidomide—leprosy	0.00571	0.00849	CcSEcCtD
Levonorgestrel—CYP19A1—testis—leprosy	0.00555	0.0169	CbGeAlD
Levonorgestrel—Dry skin—Thalidomide—leprosy	0.00552	0.00821	CcSEcCtD
Levonorgestrel—CYP19A1—nervous system—leprosy	0.00545	0.0166	CbGeAlD
Levonorgestrel—Breast disorder—Thalidomide—leprosy	0.00544	0.0081	CcSEcCtD
Levonorgestrel—Abdominal distension—Thalidomide—leprosy	0.00524	0.0078	CcSEcCtD
Levonorgestrel—Insomnia—Dapsone—leprosy	0.00523	0.00778	CcSEcCtD
Levonorgestrel—Influenza—Thalidomide—leprosy	0.00521	0.00774	CcSEcCtD
Levonorgestrel—Bronchitis—Thalidomide—leprosy	0.00501	0.00745	CcSEcCtD
Levonorgestrel—AR—testis—leprosy	0.00491	0.015	CbGeAlD
Levonorgestrel—Upper respiratory tract infection—Thalidomide—leprosy	0.00484	0.0072	CcSEcCtD
Levonorgestrel—ESR1—testis—leprosy	0.00482	0.0147	CbGeAlD
Levonorgestrel—AR—nervous system—leprosy	0.00482	0.0147	CbGeAlD
Levonorgestrel—Pollakiuria—Thalidomide—leprosy	0.00481	0.00715	CcSEcCtD
Levonorgestrel—Weight increased—Thalidomide—leprosy	0.00474	0.00705	CcSEcCtD
Levonorgestrel—ESR1—nervous system—leprosy	0.00474	0.0145	CbGeAlD
Levonorgestrel—Gastrointestinal pain—Dapsone—leprosy	0.00473	0.00704	CcSEcCtD
Levonorgestrel—Weight decreased—Thalidomide—leprosy	0.00471	0.00701	CcSEcCtD
Levonorgestrel—Pneumonia—Thalidomide—leprosy	0.00467	0.00695	CcSEcCtD
Levonorgestrel—Infestation NOS—Thalidomide—leprosy	0.00464	0.00691	CcSEcCtD
Levonorgestrel—Infestation—Thalidomide—leprosy	0.00464	0.00691	CcSEcCtD
Levonorgestrel—Depression—Thalidomide—leprosy	0.00463	0.00689	CcSEcCtD
Levonorgestrel—Abdominal pain—Dapsone—leprosy	0.00457	0.0068	CcSEcCtD
Levonorgestrel—Body temperature increased—Dapsone—leprosy	0.00457	0.0068	CcSEcCtD
Levonorgestrel—Sinusitis—Thalidomide—leprosy	0.00436	0.00648	CcSEcCtD
Levonorgestrel—Rhinitis—Thalidomide—leprosy	0.00418	0.00621	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Thalidomide—leprosy	0.00415	0.00617	CcSEcCtD
Levonorgestrel—Pharyngitis—Thalidomide—leprosy	0.00414	0.00615	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Thalidomide—leprosy	0.00412	0.00612	CcSEcCtD
Levonorgestrel—Urethral disorder—Thalidomide—leprosy	0.00409	0.00608	CcSEcCtD
Levonorgestrel—Visual impairment—Thalidomide—leprosy	0.00402	0.00597	CcSEcCtD
Levonorgestrel—Erythema multiforme—Thalidomide—leprosy	0.00394	0.00586	CcSEcCtD
Levonorgestrel—Eye disorder—Thalidomide—leprosy	0.00389	0.00579	CcSEcCtD
Levonorgestrel—Cardiac disorder—Thalidomide—leprosy	0.00387	0.00575	CcSEcCtD
Levonorgestrel—Immune system disorder—Thalidomide—leprosy	0.00376	0.0056	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Thalidomide—leprosy	0.00376	0.00559	CcSEcCtD
Levonorgestrel—Arrhythmia—Thalidomide—leprosy	0.00372	0.00554	CcSEcCtD
Levonorgestrel—Alopecia—Thalidomide—leprosy	0.00368	0.00548	CcSEcCtD
Levonorgestrel—Vomiting—Dapsone—leprosy	0.00368	0.00547	CcSEcCtD
Levonorgestrel—Mental disorder—Thalidomide—leprosy	0.00365	0.00543	CcSEcCtD
Levonorgestrel—Malnutrition—Thalidomide—leprosy	0.00363	0.0054	CcSEcCtD
Levonorgestrel—Headache—Dapsone—leprosy	0.00362	0.00539	CcSEcCtD
Levonorgestrel—Flatulence—Thalidomide—leprosy	0.00358	0.00532	CcSEcCtD
Levonorgestrel—Tension—Thalidomide—leprosy	0.00356	0.0053	CcSEcCtD
Levonorgestrel—Nervousness—Thalidomide—leprosy	0.00352	0.00524	CcSEcCtD
Levonorgestrel—Back pain—Thalidomide—leprosy	0.00351	0.00522	CcSEcCtD
Levonorgestrel—Muscle spasms—Thalidomide—leprosy	0.00349	0.00519	CcSEcCtD
Levonorgestrel—Nausea—Dapsone—leprosy	0.00344	0.00511	CcSEcCtD
Levonorgestrel—Anaemia—Thalidomide—leprosy	0.00335	0.00499	CcSEcCtD
Levonorgestrel—Angioedema—Thalidomide—leprosy	0.00332	0.00493	CcSEcCtD
Levonorgestrel—Vertigo—Thalidomide—leprosy	0.00326	0.00485	CcSEcCtD
Levonorgestrel—Syncope—Thalidomide—leprosy	0.00325	0.00484	CcSEcCtD
Levonorgestrel—Palpitations—Thalidomide—leprosy	0.00321	0.00477	CcSEcCtD
Levonorgestrel—Loss of consciousness—Thalidomide—leprosy	0.00319	0.00474	CcSEcCtD
Levonorgestrel—Cough—Thalidomide—leprosy	0.00317	0.00471	CcSEcCtD
Levonorgestrel—Hypertension—Thalidomide—leprosy	0.00313	0.00466	CcSEcCtD
Levonorgestrel—Chest pain—Thalidomide—leprosy	0.00309	0.00459	CcSEcCtD
Levonorgestrel—Myalgia—Thalidomide—leprosy	0.00309	0.00459	CcSEcCtD
Levonorgestrel—Anxiety—Thalidomide—leprosy	0.00308	0.00458	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00307	0.00456	CcSEcCtD
Levonorgestrel—Discomfort—Thalidomide—leprosy	0.00305	0.00454	CcSEcCtD
Levonorgestrel—Oedema—Thalidomide—leprosy	0.00296	0.0044	CcSEcCtD
Levonorgestrel—Infection—Thalidomide—leprosy	0.00294	0.00438	CcSEcCtD
Levonorgestrel—Shock—Thalidomide—leprosy	0.00291	0.00433	CcSEcCtD
Levonorgestrel—Nervous system disorder—Thalidomide—leprosy	0.0029	0.00432	CcSEcCtD
Levonorgestrel—Skin disorder—Thalidomide—leprosy	0.00288	0.00428	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Thalidomide—leprosy	0.00286	0.00426	CcSEcCtD
Levonorgestrel—Anorexia—Thalidomide—leprosy	0.00282	0.0042	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Thalidomide—leprosy	0.0027	0.00401	CcSEcCtD
Levonorgestrel—Insomnia—Thalidomide—leprosy	0.00268	0.00398	CcSEcCtD
Levonorgestrel—CYP3A4—nervous system—leprosy	0.00264	0.00806	CbGeAlD
Levonorgestrel—Dyspnoea—Thalidomide—leprosy	0.00264	0.00393	CcSEcCtD
Levonorgestrel—Somnolence—Thalidomide—leprosy	0.00263	0.00392	CcSEcCtD
Levonorgestrel—Dyspepsia—Thalidomide—leprosy	0.00261	0.00388	CcSEcCtD
Levonorgestrel—Decreased appetite—Thalidomide—leprosy	0.00257	0.00383	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Thalidomide—leprosy	0.00256	0.0038	CcSEcCtD
Levonorgestrel—Fatigue—Thalidomide—leprosy	0.00255	0.0038	CcSEcCtD
Levonorgestrel—Constipation—Thalidomide—leprosy	0.00253	0.00377	CcSEcCtD
Levonorgestrel—Pain—Thalidomide—leprosy	0.00253	0.00377	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Thalidomide—leprosy	0.00242	0.0036	CcSEcCtD
Levonorgestrel—Urticaria—Thalidomide—leprosy	0.00235	0.0035	CcSEcCtD
Levonorgestrel—Abdominal pain—Thalidomide—leprosy	0.00234	0.00348	CcSEcCtD
Levonorgestrel—Body temperature increased—Thalidomide—leprosy	0.00234	0.00348	CcSEcCtD
Levonorgestrel—Hypersensitivity—Thalidomide—leprosy	0.00218	0.00324	CcSEcCtD
Levonorgestrel—Asthenia—Thalidomide—leprosy	0.00212	0.00316	CcSEcCtD
Levonorgestrel—Pruritus—Thalidomide—leprosy	0.00209	0.00312	CcSEcCtD
Levonorgestrel—Diarrhoea—Thalidomide—leprosy	0.00203	0.00301	CcSEcCtD
Levonorgestrel—Dizziness—Thalidomide—leprosy	0.00196	0.00291	CcSEcCtD
Levonorgestrel—Vomiting—Thalidomide—leprosy	0.00188	0.0028	CcSEcCtD
Levonorgestrel—Rash—Thalidomide—leprosy	0.00187	0.00278	CcSEcCtD
Levonorgestrel—Dermatitis—Thalidomide—leprosy	0.00187	0.00277	CcSEcCtD
Levonorgestrel—Headache—Thalidomide—leprosy	0.00186	0.00276	CcSEcCtD
Levonorgestrel—Nausea—Thalidomide—leprosy	0.00176	0.00262	CcSEcCtD
